Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02006563 · ClinicalTrials.gov registry record

Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors

A clinical trial, sponsored by University of Miami.

Completed
Registry status
22
Enrollment target

NCT02006563: Completed study, sponsored by University of Miami.

NCT02006563 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02006563 has completed, sponsored by University of Miami.

COMPLETED
Registry status
22 participants
Enrollment target

Study Summary

* Metabolic Tumor Volume (MTV), identified by Magnetic Resonance Spectroscopic Imaging (MRSI) is different from the Clinical Target Volume (CTV) used for radiation dose delivery in the treatment of brain tumors. * If MTV \> CTV, the investigators hypothesize that the difference in volumes (cc) is related to worse clinical outcome. Furthermore, in case of local recurrence, the lesion is located in the MTV area that is outside of the CTV. * Alternatively, if CTV \> MTV, then the difference in volumes is related to higher treatment toxicity.

Primary Outcome

To evaluate the extent to which tumor volumes, determined by spectroscopic imaging (MTV) differ from the traditionally prescribed clinical treatment volumes (CTV) for radiation therapy

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2011-06-08
Est. Completion 2017-07
University of Miami

721 total trials

What the finished NCT02006563 record still lists

NCT02006563 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02006563 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02006563 about?

NCT02006563 is a clinical study titled "Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors". * Metabolic Tumor Volume (MTV), identified by Magnetic Resonance Spectroscopic Imaging (MRSI) is different from the Clinical Target Volume (CTV) used for radiation dose delivery in the treatment of brain tumors. * If MTV \> CTV, the investigators hypothesize that the difference in volumes (cc) is re...

What is the current status of trial NCT02006563?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-06-08. Estimated completion is 2017-07.

Who is sponsoring clinical trial NCT02006563?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02006563, the US trial registry maintained by the National Library of Medicine. NCT02006563 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.